Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens

被引:84
作者
Chelvarajan, RL
Collins, SM
Doubinskaia, IE
Goes, S
Van Willigen, J
Flanagan, D
de Villiers, WJS
Bryson, JS
Bondada, S
机构
[1] Univ Kentucky, Dept Microbiol & Immunol, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA
[3] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
关键词
B lymphocytes; cytokines; LPS; suppression;
D O I
10.1189/jlb.0403179
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neonates do not respond to thymus-independent (TI) antigens (Ag), making them vulnerable to infection with encapsulated bacteria. The antibody (Ab) response of adult and neonatal B cells to TI Ag requires certain cytokines, which are provided by T cells or macrophages (MO). Lipopolysaccharide (LPS) failed to induce neonatal MO to produce interleukin (IL)-1beta and tumor necrosis factor alpha (TNF-alpha) mRNA and to secrete IL-1beta, IL-12, and TNF-alpha. However, LPS induced neonates to secrete some IL-6 and three- to fivefold more IL-10 than adults. Accordingly, adding adult but not neonatal MPhi could restore the response of purified adult B cells to trinitrophenol (TNP)-LPS, a TI Ag. Increased IL-10 is causally related to decreased IL-1beta and IL-6 production, as IL-10(-/-) neonatal MPhi responded to LPS by secreting more IL-1beta and IL-6 than wild-type (WT) neonatal MO. When cultures were supplemented with a neutralizing Ab to IL-10, WT neonatal MPhi secreted increased amounts of IL-6 and allowed neonatal MPhi to promote adult B cells to mount an Ab response against TNP-LPS. Thus, neonates do not respond to TI Ag as a result of the inability of neonatal MPhi to secrete cytokines, such as IL-1beta and IL-6, probably as a result of an excess production of IL-10. This dysregulated cytokine secretion by neonatal MPhi may be a result of a reduction in expression of Toll-like receptor-2 (TLR-2) and TLR-4 and CD14.
引用
收藏
页码:982 / 994
页数:13
相关论文
共 57 条
[1]  
Adkins B, 2000, Int Rev Immunol, V19, P157, DOI 10.3109/08830180009088503
[2]   Exclusive Th2 primary effector function in spleens but mixed Th1/Th2 function in lymph nodes of murine neonates [J].
Adkins, B ;
Bu, YR ;
Cepero, E ;
Perez, R .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2347-2353
[3]  
Aggarwal B., 2001, CYTOKINE REFERENCE C, V1, P413
[4]   Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages [J].
Akashi, S ;
Shimazu, R ;
Ogata, H ;
Nagai, Y ;
Takeda, K ;
Kimoto, M ;
Miyake, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3471-3475
[5]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[6]   Accessory cell defect in unresponsiveness of neonates and aged to polysaccharide vaccines [J].
Bondada, S ;
Wu, HJ ;
Robertson, DA ;
Chelvarajan, RL .
VACCINE, 2000, 19 (4-5) :557-565
[7]  
BONDADA S, 1994, HDB B T LYMPHOCYTES, P343
[8]  
Bondeson J, 1999, J IMMUNOL, V162, P2939
[9]   A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages [J].
Brightbill, HD ;
Plevy, SE ;
Modlin, RL ;
Smale, ST .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1940-1951
[10]  
Chelvarajan RL, 1999, EUR J IMMUNOL, V29, P2808, DOI 10.1002/(SICI)1521-4141(199909)29:09<2808::AID-IMMU2808>3.0.CO